Cargando…
Design of a randomized controlled trial for genomic carrier screening in healthy patients seeking preconception genetic testing
Population-based carrier screening is limited to well-studied or high-impact genetic conditions for which the benefits may outweigh the associated harms and costs. As the cost of genome sequencing declines and availability increases, the balance of risks and benefits may change for a much larger num...
Autores principales: | Kauffman, Tia L., Wilfond, Benjamin S., Jarvik, Gail P., Leo, Michael C., Lynch, Frances L., Reiss, Jacob A., Richards, C. Sue, McMullen, Carmit, Nickerson, Deborah, Dorschner, Michael O., Goddard, Katrina A.B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5274557/ https://www.ncbi.nlm.nih.gov/pubmed/27940182 http://dx.doi.org/10.1016/j.cct.2016.12.007 |
Ejemplares similares
-
“Is It Worth Knowing?” Focus Group Participants’ Perceived Utility of Genomic Preconception Carrier Screening
por: Schneider, Jennifer L., et al.
Publicado: (2015) -
Time Costs for Genetic Counseling in Preconception Carrier Screening with Genome Sequencing
por: Lynch, Frances L., et al.
Publicado: (2018) -
Genome sequencing and carrier testing: decisions on categorization and whether to disclose results of carrier testing
por: Himes, Patricia, et al.
Publicado: (2017) -
Assessment of willingness to pay for expanded carrier screening among women and couples undergoing preconception carrier screening
por: Clarke, Elizabeth V., et al.
Publicado: (2018) -
A case for expanding carrier testing to include actionable X‐linked disorders
por: Rope, Alan F., et al.
Publicado: (2018)